JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in JNM
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Choi, J. Y.
Right arrow Articles by Kim, B.-T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Choi, J. Y.
Right arrow Articles by Kim, B.-T.

18F-FDG PET in Patients with Esophageal Squamous Cell Carcinoma Undergoing Curative Surgery: Prognostic Implications

Joon Young Choi, MD1, Hong-Ju Jang, MD1, Young Mog Shim, MD2, Kwhanmien Kim, MD2, Kyung Soo Lee, MD3, Kyung-Han Lee, MD1, Yong Choi, PhD1, Yearn Seong Choe, PhD1 and Byung-Tae Kim, MD1

1 Department of Nuclear Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
2 Department of Thoracic Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
3 Department of Radiology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea



View larger version (18K):

[in a new window]
  		FIGURE 1. Overall survival curves according to pathologic stage.

 


View larger version (19K):

[in a new window]
  		FIGURE 2. Overall survival curves according to tumor length on PET.

 


View larger version (19K):

[in a new window]
  		FIGURE 3. Overall survival curves according to number of PET-positive lymph nodes.

 


View larger version (17K):

[in a new window]
  		FIGURE 4. Overall survival curves according to number of PET-positive lymph nodes in subgroup of patients with pathologic stage III disease.

 


View larger version (18K):

[in a new window]
  		FIGURE 5. Overall survival curves according to number of PET-positive lymph nodes in subgroup of patients with pathologic stage IV disease.

 




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2004 by the Society of Nuclear Medicine.